Načítá se...
Harnessing Hidden Anti-Tumor Power of MLL-AF4 Oncogene to Fight Leukemia
It is unclear whether the anti-proliferative/pro-apoptotic activity of oncogenes can be pharmacologically reactivated in cancer cells. In this issue of Cancer Cell, Liu and colleagues report that a proteasome inhibitor reactivates an MLL-AF4 controlled anti-tumor program to kill leukemia cells in an...
Uloženo v:
| Vydáno v: | Cancer Cell |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4711792/ https://ncbi.nlm.nih.gov/pubmed/24735921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccr.2014.03.028 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|